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Abstract 
The electrochemical oxidation of nevirapine, an anti-HIV drug, at a gold electrode was 
studied by voltammetric techniques. Nevirapine showed a signal that interfered with a 
working electrode wave. This interference was solved by the use of cucurbit(7)uril 
allowing nevirapine to be determined in tablets (80.4 % recovery, presence of stavudine 
and lamivudine) and urine (98.4 %). 
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Introduction 
Nevirapine (NEV, Figure 1) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV-1 
that causes acquired immunodeficiency syndrome (AIDS). The drug directly bounds to and blocks 
the activities of RNA and DNA polymerases, both dependent, which caused breakdown of the 
enzyme catalytic site. NEV activity was not competitive with the reverse transcriptase enzyme or 
with nucleoside triphosphates. Reverse transcriptase (RT) of HIV-2 and DNA polymerases of 
eukaryotic cells (eg. human DNA polymerases alpha, beta, gamma and sigma) were not inhibited 
by nevirapine. The in-vitro antiviral activity was determined in peripheral blood mononuclear cells 
(PBMC), monocyte-derived macrophages and a lymphoblastoid cell line. The values of the 50 % 
inhibitory concentrations (IC50) were in the range of 10 to 100 µM against laboratory and clinical 
isolates of HIV-1. In cell cultures, nevirapine demonstrated additive to synergistic action against 
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HIV-1 in combination regimens with zidovudine, didanosine, stavudine, lamivudine, saquinavir and 
indinavir [1]. 
 
Figure 1. Nevirapine; 11-cyclopropyl–5,11–dihydro–4–methyl–6H di- 
pyrido[3,2–b:2′,3′-e]-[1,4]diazepin–6–one. 
Different analytical techniques were used to detect NEV, including high performance liquid 
chromatography (HPLC) [2], matrix-assisted laser desorption/ionization-time of flight mass 
spectrometry (MALDI-TOF) [3], and capillary electrophoresis [4]. These techniques require expen-
sive equipment, costly reagents for sample preparation and analysis and quite some time. 
Electroanalytical methods are an accurate and cheap alternative which offer very low detection 
limits for electroactive molecules. Different drugs were determined by this technique achieving 
very low detection limits [5]. Some articles have recently been published about the 
electroanalytical determination of NEV by means of different working electrodes [6-8]. 
The family of compounds of cucurbit(n)urils (CB(n)) are polymeric macrocycles obtained by the 
condensation reaction of glicoluryl and formaldehyde in acid conditions and have n units of glico-
luryl bridged by methylene groups. They bind molecules by hydrophobic and ion-dipole 
interactions (but not exclusively) due to the cavity portals delineated by a rim of carbonylic 
oxygens. The hydrophobic cavity allowed the inclusion of different molecules depending on the 
CB(n) homologue and the size of the guest [9,10]. 
We developed a method for the analysis of NEV using CB(7) and gold electrode. Low detection 
limits were obtained. The method was applied to biological fluids (urine) and a pharmaceutical 
formulation (which also contained lamivudine and stavudine) and it was demonstrated that the 
methodology had fewer steps than other ones. 
Experimental  
Reagents 
NEV was provided by the Center for State Control of Drugs (CECMED-Cuba). Aqueous solutions 
of the analyte were prepared at a 2 mg mL-1 concentration in acid medium (pH < 3). Diluted 
solutions were prepared in supporting electrolyte just before use. CB(7) was supplied by Sigma-
Aldrich Chemical Co. All reagents were of analytical grade (> 98  %) and were provided by Scharlau. 
Ultrapure water was produced by a Milli-Ro and Milli-Q system (Millipore, Waters). Solutions of 
these compounds were stored at 4 °C and protected from light. Britton-Robinson buffer solutions 
(BR, mixture of boric, acetic and phosphoric acids) were used as supporting electrolytes, prepared 
at a final concentration of 0.04 M and the buffer pH was adjusted with 0.1 M NaOH. 
NEV was determined in a tablet sample whose nominal content was 250 mg per tablet together 
with 40 mg of stavudine and 150 mg of lamivudine. A tablet was dissolved in methanol and filtered 
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through a cellulose membrane of 0.45 µm pore size to get a 2.5 mg mL-1 NEV solution which was 
stored at 4 °C. 
Apparatus 
Electrochemical measurements were performed by means of a μAutolab III potentiostat made 
by Eco-Chemie in a three electrodes cell: an Au working electrode (2.01 mm2 geometric area) 
provided by BAS, a coiled platinum wire as counter electrode and an Ag/AgCl (3 M KCl) reference 
electrode (all potentials in this paper were referred against it). The pH was controlled by means of 
a Methrom 827 pH meter with combined glass and an Ag/AgCl/ (3 M KCl) electrode. 
Procedure 
Activation and regeneration of the gold electrode surface was carried out by successive 
scanning in 0.1 M sulphuric acid between 0.0 V and 1.5 V at 100 mV s-1 by cyclic voltammetry (CV). 
An ultrasonic bath was used to clean the electrode surface when required and prior to the 
described activation procedure. Differential pulse voltammetry (DPV) was the chosen technique 
for the analyte determination in solutions of a NEV:CB(7) ratio of 1:2, the measurements started at 
0.4 V and the chosen scan rate and pulse amplitude were 25 mV s-1 and 25 mV, respectively. 
Results and Discussion 
Our studies were performed with NEV at a concentration of 100 µM (26.6 µg mL-1) by CV at gold 
electrode in 0.04 M BR buffer at pH 2. The analyte showed irreversible redox behaviour and a 
reduction wave was observed at 0.66 V. As it can be seen in Figure 2, a broad and intense signal at 
1.14 V was seen in the anodic scan (green line) but close to the gold oxidation wave at 1.3 V (black 
line). It shifted to potential values lower than 1.1 V between pH 2 and 6 until disappearance at 




Figure 2. Cyclic voltammograms of NEV at 100 mV s-1 in 0.04 M BR buffer at pH 2. Black line, 
supporting electrolyte; red line, 20 µM CB(7); green line, 100 µM NEV; blue line, 10 µM NEV; 
cyan line, 10 µM NEV and 20 µM CB(7). 
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An increase in the sweep rate (Vb) between 10 and 400 mV s
-1 entailed a variation of the 
intensity and potential of the signals when a 266 µg mL-1 analyte solution in 0.04 M BR at pH 2 was 
analysed. When the logarithm of the anodic peak current was represented versus the logarithm of 
the scan rate in Figure 3 (black points), a straight line was obtained with a 0.53 slope value (close 
to 0.5) so the oxidation could happen after diffusion of the analyte to the electrode surface. 
However, it was showed in Figure 2 (green line) that NEV was oxidized by means of at least two 
processes and its shape was not a diffusion-like one so the 0.53 slope value was a chance. The 
dependence between the logarithm of the cathodic peak current of the NEV oxidation product and 
the logarithm of the scan rate was studied (Figure 3, red points) and a slope close to 1 was found 
so the reduction of that product could be concomitant with an adsorption process. Nevertheless, 




Figure 3. Effect of the change of the scan rate on the oxidation (black points and line)  
and reduction peak currents (red points and line). 
As before stated, the NEV oxidation wave was at a potential very close to the gold oxides 
formation one so the measurements analysis could be complicated or even impossible if the 
analyte concentrations of the sample solution were low, as in the case of a 10 µM NEV (blue line, 
Figure 2). When CB(7) was added to solutions of this low NEV concentration (10 µM NEV and 20 
µM CB(7), cyan line, Figure 2), the anodic signals were more separated, the NEV wave was 
narrower and a huge increase in the peak current was observed when they were compared to the 
signal of solutions of the same analyte concentration and no added CB(7) (blue line, Figure 2). 
Voltammetric measurements of blank solutions of CB(7) did not show any signal but the same 
waves observed when the cell just contained supporting electrolyte, as it can be seen in Figure 2, 
red and black lines, respectively. 
If a 1:2 NEV:CB(7) molar ratio was kept constant, the separation of NEV and gold waves in the 
anodic scan observed at pH 2 in Figure 2 (cyan line) continued up to neutral pH. In these 
conditions, the NEV cathodic signal was not observed at pH higher than 2. The peak potential (Ep) 
depended on the medium pH so it can be concluded that the anodic reaction was coupled to an 
acid-base one. In this case, this dependence followed a straight line whose equation was 
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Ep / V = 1.19 - 0.021 pH (R
2 = 0.998). As the line slope value (dEp/dpH) was close to 0.029 V per pH 
unit, the number of exchanged protons was the half of the number of electrons according to the 
Nernst equation. 
The stoichiometric NEV:CB(7) ratio was studied by CV in 0.04 M BR buffer pH 2, at a constant 
CB(7) concentration and changing NEV concentration, and vice versa. Current and potential values 
were plotted and the slope change depending on the NEV:CB(7) ratio was indicative of successive 
formation of NEV-CB(7) complexes of 1:2 stoichiometry. 
As it is shown in Figure 4, the effect of the concentration (0.3-1.6 μg mL-1) on the signal was 
studied at a 1:2 NEV:CB(7) ratio in 0.04 M BR pH 2 by DPV. Therefore, what it was done was to 
augment the analyte concentration but also the macrocycle one in the measured solutions. The 
peak current and the concentration were directly proportional up to 1 µg mL-1, data points that 
were fitted to Ip / µA = -0.038 + 4.300c / µg mL
-1, R2=0.999. For higher concentrations the analytical 
signal was relatively constant probably due to surface saturation. 
 
 
Figure 4. Effect of the concentration of NEV on the DPV measurements, at a constant  
NEV:CB(7) ratio of 1:2 in 0.04 M BR pH 2 (see text). The voltammograms of the NEV  
concentrations 0.267, 0.534, 0.801, 1.07 µg mL-1 are shown. The inset graph gives  
the peak current vs. NEV concentration. 
CV measurements of approximately 200 µg mL-1 stavudine and lamivudine solutions in 
0.04 M BR were obtained at different pH. DPV measurements of these two interferences at pH 6 
are shown in Figure 5 and it can be seen that the lamivudine reduction signal was at -0.2 V (red 
line) and the stavudine one was at -0.1 V (black line). They both were well defined when CB(6) or 
CB(7) were present in the solution. The signal could be a product of the possible formation of 
inclusion complexes. These compounds did not show oxidation signals so did not interfere in NEV 
determination by DPV when they were in the analysed sample. 
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Figure 5. DPV measurements of 4 µM stavudine and lamivudine and with CB(7) (1:2) in pH 6 BR 
buffer as electrolyte. Black line, stavudine; red line, lamivudine; green line, electrolyte. 
Determination in tablet 
A crushed tablet was left in contact with methanol for 24 hours, the suspension was filtered, 
the resulting solution was transferred to a 100 mL volumetric flask and the volume was completed 
with methanol. It contained 2.5 mg mL-1 of NEV and the working solutions were prepared from this 
one. Voltammograms of sample solutions were recorded and, as it can be seen in Figure 6 and as 
previously shown, the gold oxidation and NEV waves were overlapped if no CB(7) had been added 
but they were separated if the macrocycle was present (1:2 NEV:CB(7) ratio). The results obtained 
by means of the standard addition method showed that the content of NEV/tablet was 80.4% of 
the nominal one (n = 4) in the presence of stavudine and lamivudine. 
 
 
Figure 6. DPV measurements of solutions of the pharmaceutical sample in 0.04 M BR buffer pH 
2. Black line, no CB(7) in solution; red line, with CB(7) (ration 1:2 NEV:CB(7)). 
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Determination in urine 
A previous treatment of liquid-liquid extraction was necessary given the complexity and 
characteristics of the urine sample. 2 mL of urine of a healthy individuals were spiked with NEV to 
reach a final concentration of 26 µg mL-1 and were subjected to liquid-liquid extraction with 10 mL 
of diethyl ether. After shaking, the liquid was left for 3 min, the aqueous phase was discarded and 
the organic one was evaporated. 10 mL of 0.04 M BR buffer pH 2 were used to dissolve the 
residue, the solution was introduced in the electrochemical cell and DPV measurements of 
increasing concentrations of NEV were performed to analyse the sample, voltammograms that are 
shown in Figure 7. A recovery of 98.4 % (n = 3) was obtained for the spiked urine with 26 µg mL-1 
NEV in presence of CB(7). 
 
 
Figure 7. DPV measurements of NEV doped urine with successive additions of the drug in 
presence of CB(7), maintaining the 1:2 ratio. Black line, 0 µg mL-1 NEV added; red line, 
5.32 µg mL-1; green line, 10.6 µg mL-1. 
Conclusions 
An electroanalytical method was developed for the analysis of NEV in pharmaceutical 
formulations in the presence of stavudine and lamivudine and in urine by means of a gold 
electrode and DPV. NEV was electroactive between pH 2 and 6 and CV measurements showed that 
NEV oxidation wave was very close to the gold oxides formation one but if CB(7) was added to a 
NEV solution, both waves were separated and an increase in the analyte peak current was 
observed. Measurements in 0.04 M BR buffer pH 2 were performed to get the stoichiometry of the 
NEV-CB(7) complex behind this electrochemical behaviour and it was found that one NEV 
molecule interacted with two CB(7) molecules, ratio which was kept constant in every calibration 
or analyzed sample. The calibration of the response was performed and found the equation 
Ip / µA = -0.038 + 4.300c / µg mL
-1, R2=0.999. The analysis of tablets gave an 80.4 % recovery (n = 4) 
just dissolving the sample in methanol. 2 mL of urine were doped with NEV at a concentration of 
26 µg mL-1 and were subjected to liquid-liquid extraction due to the complex matrix and a 98.4 % 
recovery (n = 3) was found. 
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